LNKB vs RARE · P/E 7.9, rev $167.6M vs rev $350.0M
LINKBANCORP Inc (LNKB) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
LINKBANCORP Inc (LNKB) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported LNKB revenue for 2024-12-31 was $167.6M. Net income was $26.2M. Revenue was up 152.8% from 2023-12-31 to 2024-12-31. LNKB currently screens at market cap $286.7M and trailing P/E 7.9.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
LNKB currently screens at market cap $286.7M and trailing P/E 7.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the LNKB and RARE stock pages for the full models.
Not investment advice.